Actively Recruiting
Effects of Low-Energy Ultrasound on Spleen Platelet Activity and Blood Clotting in Healthy Adults
Led by Northwell Health · Updated on 2026-08-27
39
Participants Needed
1
Research Sites
3 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a randomized, double-blinded, sham-controlled early feasibility trial to explore whether low-energy ultrasound targeted to the spleen can affect platelet activity and blood clotting markers. The study involves healthy adults aged 18 to 50 years and aims to understand organ-specific biological effects on blood coagulation through ultrasound stimulation. Participants are assigned to one of three groups receiving different ultrasound treatments focused insonification at the spleens center, prolonged insonification at the center, or prolonged insonification across the spleen. Each participant first receives 30 minutes of sham stimulation followed by active ultrasound stimulation within their assigned group. Blood samples are collected before and at multiple timepoints after stimulation to assess molecular and cellular changes. During the study, participants will undergo ultrasound sessions and blood biomarker testing to monitor the effects on hemostasis within four hours. The study requires adherence to scheduled visits around the same time of day and involves careful monitoring of blood biomarkers related to coagulation. The total participation period encompasses the ultrasound procedure and post-stimulation assessments to evaluate changes in blood clotting markers.
CONDITIONS
Brief Title
Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.
Research Team
M
Maaryj Ahmad
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here